These unwanted effects are considered as a class effect, because all anti-TNF drugs appear to have an equally high risk in acquiring new tuberculosis infections, although the mAbs seem to cause more infections with reactive latent tuberculosis [304]. The gene discussed is TNF; the disease is infection.